Terms: = Liver cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Prognosis
31 results:
1. Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and rac1 in hepatocellular carcinoma cells.
Koch DT; Yu H; Beirith I; Schirren M; Drefs M; Liu Y; Knoblauch M; Koliogiannis D; Sheng W; De Toni EN; Bazhin AV; Renz BW; Guba MO; Werner J; Ilmer M
J Transl Med; 2023 Dec; 21(1):876. PubMed ID: 38041179
[TBL] [Abstract] [Full Text] [Related]
2. Integrated analysis of tumour-derived exosome-related immune genes to predict progression and immune status of hepatocellular carcinoma.
Li W; Zhao B; Wang Q; Lu J; Wu X; Chen X
Clin Immunol; 2023 Nov; 256():109774. PubMed ID: 37774907
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of novel signature associated with hepatocellular carcinoma prognosis using Single-cell and WGCNA analysis.
Song H; Ge Y; Xu J; Shen R; Zhang PC; Wang GQ; Liu B
Int J Med Sci; 2023; 20(7):870-887. PubMed ID: 37324188
[No Abstract] [Full Text] [Related]
4. N
Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
[TBL] [Abstract] [Full Text] [Related]
5. FMRP ligand circZNF609 destabilizes rac1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma.
Shang Q; Du H; Wu X; Guo Q; Zhang F; Gong Z; Jiao T; Guo J; Kong Y
J Exp Clin Cancer Res; 2022 May; 41(1):170. PubMed ID: 35534866
[TBL] [Abstract] [Full Text] [Related]
6. Overexpressed or hyperactivated rac1 as a target to treat hepatocellular carcinoma.
Sauzeau V; Beignet J; Vergoten G; Bailly C
Pharmacol Res; 2022 May; 179():106220. PubMed ID: 35405309
[TBL] [Abstract] [Full Text] [Related]
7. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and rac1.
Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
[TBL] [Abstract] [Full Text] [Related]
8. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance rac1-ERK-STAT3 signaling in hepatocellular carcinoma.
Wang LL; Luo J; He ZH; Liu YQ; Li HG; Xie D; Cai MY
Cell Death Dis; 2021 Nov; 12(11):1052. PubMed ID: 34741044
[TBL] [Abstract] [Full Text] [Related]
9. T-lymphoma invasion and metastasis 1 promotes invadopodia formation and is regulated by the PI3K/Akt signaling pathway in hepatocellular carcinoma.
Wang B; Zheng B; Cao L; Liao K; Huang D; Zhang Y; Jiang Y; Zheng S
Exp Cell Res; 2021 Oct; 407(2):112806. PubMed ID: 34487727
[TBL] [Abstract] [Full Text] [Related]
10. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
Li J; Tian L; Jing Z; Guo Z; Nan P; Liu F; Zou S; Yang L; Xie X; Zhu Y; Zhao Y; Sun W; Sun Y; Zhao X
Cancer Lett; 2021 Sep; 516():13-27. PubMed ID: 34062216
[TBL] [Abstract] [Full Text] [Related]
11. Bioinformatic analysis of RHO family of GTPases identifies rac1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma.
Bayo J; Fiore EJ; Dominguez LM; Cantero MJ; Ciarlantini MS; Malvicini M; Atorrasagasti C; Garcia MG; Rossi M; Cavasotto C; Martinez E; Comin J; Mazzolini GD
Gut; 2021 Jul; 70(7):1362-1374. PubMed ID: 33106353
[TBL] [Abstract] [Full Text] [Related]
12. DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits.
Chi HC; Tsai CY; Wang CS; Yang HY; Lo CH; Wang WJ; Lee KF; Lai LY; Hong JH; Chang YF; Tsai MM; Yeh CT; Wu CH; Hsieh CC; Wang LH; Chen WJ; Lin KH
Oncogene; 2020 Sep; 39(37):5933-5949. PubMed ID: 32753649
[TBL] [Abstract] [Full Text] [Related]
13. IQGAP1 promotes anoikis resistance and metastasis through rac1-dependent ROS accumulation and activation of Src/FAK signalling in hepatocellular carcinoma.
Mo CF; Li J; Yang SX; Guo HJ; Liu Y; Luo XY; Wang YT; Li MH; Li JY; Zou Q
Br J Cancer; 2020 Sep; 123(7):1154-1163. PubMed ID: 32632148
[TBL] [Abstract] [Full Text] [Related]
14. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.
Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J
Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215
[No Abstract] [Full Text] [Related]
15. CAMSAP2-mediated noncentrosomal microtubule acetylation drives hepatocellular carcinoma metastasis.
Li D; Ding X; Xie M; Huang Z; Han P; Tian D; Xia L
Theranostics; 2020; 10(8):3749-3766. PubMed ID: 32206120
[No Abstract] [Full Text] [Related]
16. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and rac1/PAK signaling.
Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
[TBL] [Abstract] [Full Text] [Related]
17. Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-rac1 integrin and MEK-ERK pathways.
Sun X; Liu S; Wang J; Wei B; Guo C; Chen C; Sun MZ
Cell Death Dis; 2018 May; 9(6):637. PubMed ID: 29802377
[TBL] [Abstract] [Full Text] [Related]
18. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG
Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144
[TBL] [Abstract] [Full Text] [Related]
19. Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade.
Yu H; Shen Y; Jin J; Zhang Y; Feng T; Liu X
Cell Adh Migr; 2018 Jan; 12(1):56-68. PubMed ID: 28636424
[TBL] [Abstract] [Full Text] [Related]
20. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
[TBL] [Abstract] [Full Text] [Related]
[Next]
